| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AXIM BIOTECHNOLOGIES, INC. | 10%+ Owner | Common Stock | 28,608,220 | 30 Jan 2024 | Direct | ||
| AXIM BIOTECHNOLOGIES, INC. | 10%+ Owner | Convertible Note | 7,837,500 | 15 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AXIM | AXIM BIOTECHNOLOGIES, INC. | 15 Mar 2024 | 1 | +$1,228,528,125,000 | 4 | 10%+ Owner | 19 Mar 2024, 19:39 |
| AXIM | AXIM BIOTECHNOLOGIES, INC. | 30 Jan 2024 | 1 | $0 | 4 | President and Director, Director, 10%+ Owner | 15 Oct 2024, 17:05 |
| AXIM | AXIM BIOTECHNOLOGIES, INC. | 29 Aug 2022 | 1 | +$100,000 | 4 | 10%+ Owner | 31 Aug 2022, 16:01 |
| AXIM | AXIM BIOTECHNOLOGIES, INC. | 19 Mar 2020 | 0 | $0 | 3 | 10%+ Owner | 31 Aug 2022, 15:40 |